The trajectory of copyright's flagship drug presents a interesting case for investors in the drug sector. While initially a tremendous success, generating vast sums, the exclusivity lapse and the subsequent flood of https://porn102627.theideasblog.com/42241142/the-little-copyright-and-pharma-a-risky-investment